Applied Tissue Technologies LLC

Las Vegas-based New Horizon Medical Solutions announced it has acquired Applied Tissue Technologies' transparent negative-pressure wound therapy device and micrografting kit, expanding its portfolio of wound care offerings. New Horizon offers biologics and advanced wound care tools, including skin substitutes developed using amniotic membrane technology. The company also offers workflow and staff training tools, as well as technology integration services, aimed at reducing administrative burden, improving patient satisfaction, and strengthening documentation and claims. Boston-based Applied Tissue is another wound care company that offers proprietary devices to help wounds heal more quickly. It offers negative-pressure wound therapy technology, including its Xpansion micro-autografting kit, which the company says allows clinicians to expand the donor-to-coverage ratio for autografts. "Together, these and other recent additions to our portfolio begin to distinguish us from others and make us a formidable industry partner," Will Hall, CEO of New Horizon Medical Solutions, said in a statement. THE LARGER TREND 2025 has seen a flurry of mergers and acquisitions in the healthcare technology space. In January, Transcarent , an employee healthcare navigation company, entered into a definitive agreement to acquire health benefits platform Accolade for around $621 million, or $7.03 per share in cash. The merger was completed in April. In February, New York-based virtual care company Teladoc Health announced it had signed a definitive agreement to acquire virtual preventive care company Catapult Health in an all-cash deal valued at $65 million, with an additional $5 million in contingent earnout consideration. April saw Willow , maker of wearable breast pumps, acquire British femtech company Elvie to scale the companies' maternal health platforms, and in May, Datavant, a data sharing technology company, announced its plans to acquire Aetion , a company focused on real-world evidence in healthcare. In June, Christopher McGhee, cofounder and former CEO of Current Health , reacquired the company from Best Buy , which had purchased it in 2021 for $400 million. A month later, healthcare company Astrana Health announced it finalized its acquisition of Prospect Health , an integrated care delivery network, for $708 million, slightly below the originally announced $745 million. Teladoc made another acquisition in August, purchasing Telecare, a virtual care provider in Australia, expanding its specialist network in the region. That same month, Datavant finalized its second acquisition of the year, acquiring Ontellus , a provider of health records retrieval and claims intelligence. October saw numerous deals in the space. NeueHealth , a company that connects providers and payers with technology to enable value-based care, closed its previously announced merger by an affiliate of New Enterprise Associates at an enterprise value of approximately $1.465 billion, a $165 million increase from its initially projected price in January. The acquisition led to NeueHealth's stock [NYSE: NEUE] being delisted from the New York Stock Exchange as of Oct. 2.​ That same month, virtual behavioral healthcare provider Talkspace announced it acquired Wisdo Health , a social health and peer-support platform focused on combating loneliness, and telehealth and medical transportation company DocGo announced it acquired telehealth provider SteadyMD . ​Datavant completed its third acquisition of the year in October, acquiring medical data analysis company DigitalOwl . ​In early December, tech-enabled clinical research platform Paradigm Health secured $78 million in an oversubscribed Series B financing round and announced its acquisition of oncology-focused digital health company Flatiron Health's Clinical Research Business.

Hingham, Massachusetts--(News - April 15, 2021) - Applied Tissue Technologies (ATT), an advanced wound care company, announced the publication of a peer reviewed study in Plastic and Reconstructive Surgery Journal® Global Open, "Utilization of a Novel Negative Pressure Platform Wound Dressing on Surgical Incisions: A Case Series". To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Additional Clinical Trial Data to come later in 2021. The FDA cleared, patented PWD is completely transparent, allowing for ongoing visual assessment of the wound without removing the dressing. A Newly Developed, Single-Use Pump will be launched later in 2021. The pump will have a fixed pressure, single button operation and a canister. It will be very compact, similar in size to a small mobile phone. Click image above to view full announcement. Applied Tissue Technologies brings advancements in wound healing to patients. This includes research and development supported by the United States Department of Defense to help wounded warriors at the point of injury, instances of prolonged field care and delayed evacuation, and also continuing through advanced levels of military medical care. @npwtsimplified The PWD is supported in part by the United States Defense Health Agency (Small Business Innovation Research), USAMRAA, and USAMRMC through contract numbers W81XWH-18-2-0002, W81XWH-18-C-0143, W81XWH-19-2-0038 and W81XWH-16-0784. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. Contacts: Michael Broomhead 781-366-3848 michael.broomhead@appliedtissue.com Source: Applied Tissue Technologies To view the source version of this press release, please visit